SCHEMBL1386804

SCHEMBL1386804

O=C1CN(S(=O)(=O)c2cc3ccccc3s2)CCN1Cc1cc2cnccc2[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 1.00
F2 P00734 2/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1652596 0.89 F10 (0.81) F10F2
SCHEMBL1652235 0.89 F10 (1.00) F10F2
SCHEMBL1384898 0.89 F10 (1.00) F10F2
SCHEMBL1654016 0.88 F10 (0.79) F10F2
SCHEMBL1653531 0.88 F10 (0.78) F10F2
SCHEMBL1653322 0.88 F10 (0.79) F10F2
SCHEMBL1653356 0.87 F10 (0.77) F10F2
SCHEMBL1653170 0.87 F10 (0.78) F10F2
SCHEMBL4399062 0.85 F10 (0.74) F10F2
SCHEMBL4399064 0.85 F10 (0.74) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed